Atlanta is a hidden gem in the national medical device innovation ecosystem. We recently detailed the top reasons why on the T3 blog. Last week, Tif Wilson, executive director of the Global Center for Medical Innovation and T3 Labs advisory board chair, along with Andrew Stevenson, executive director of T3 Labs spoke at length about medtech innovation with CW Hall and Diana Keough on Health Connect South Radio.
Improving Atlanta’s ecosystem for medical device innovation and emerging healthcare technology companies.
As CW wrote:
“This week we hosted experts from the Global Center for Medical Innovation (GCMI) and T3 Labs. These two non-profit organizations are dedicated to providing an ecosystem and an environment that start-up healthcare technology companies can use to develop prototypes for new devices, as well as early stage production for them as they build toward commercialization.
Executive Director for GCMI, Tif Wilson, and Executive Director for T3 Labs, Andrew Stevenson, came by to talk about how their organizations are working to expand and improve the ecosystem for emerging healthcare technology companies.”
Access via Hartsfield-Jackson International Airport, readily available engineering talent, clinicians and growth in the investor community have positioned Atlanta for fast growth in the medical device innovation industry.
Getting New Medical Devices To Market Faster.
“The bottom line is always improvement in patient care,” Tif says. “But from an organizational and process standpoint, GCMI and T3 Labs are always working to make the medical device innovation process more efficient in order to get technologies to market faster, develop more successful medtech startups, and encourage job growth and investment in the Atlanta region,” Tif says.
Listen along as Tif and Andrew share their insights on what it takes to build a robust medical device innovation ecosystem.
[soundcloud url=”https://api.soundcloud.com/tracks/231394069″ params=”auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false&visual=true” width=”100%” height=”450″ iframe=”true” /]
Connect With T3 Labs
If your company is evaluating a product’s readiness for FDA including preclinical testing, contact our team at 404-251-0600 or email@example.com. Connect with T3 Labs on LinkedIn.